GFM
ONC

GF Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

GF Fund Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194K Sell
680
-27
-4% -$7.96K ﹤0.01% 279
2026
Q1 		$210K Buy
707
+90
+15% +$29.1K ﹤0.01% 281
2025
Q4 		$187K Sell
617
-106
-15% -$34.7K ﹤0.01% 302
2025
Q3 		$246K Sell
723
-412
-36% -$125K ﹤0.01% 269
2025
Q2 		$275K Hold
1,135
– – 0.01% 294
2025
Q1 		$309K Buy
+1,135
New +$265K 0.01% 289

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GF Fund Management's ONC Position: Q2 2026 in Review

GF Fund Management reduced its BeOne Medicines Ltd (ONC) stake by 3.8% in Q2 2026, selling an estimated $7.96K and leaving 680 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #279.

GF Fund Management first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. The position peaked at $309K in Q1 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • GF Fund Management held 680 shares of BeOne Medicines Ltd worth $194K as of Q2 2026.
  • GF Fund Management sold 27 BeOne Medicines Ltd shares in Q2 2026, an estimated $7.96K.
  • BeOne Medicines Ltd made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #279 holding.
  • GF Fund Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
  • GF Fund Management's BeOne Medicines Ltd position peaked at $309K in Q1 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.